CTCBIO Inc. (KOSDAQ:060590)
South Korea
· Delayed Price · Currency is KRW 3,910.00
+50.00 (1.30%)
At close: Apr 29, 2026
CTCBIO Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 123,769 | 119,877 | 137,878 | 165,206 | 140,318 | Upgrade
|
| Other Revenue | -0 | -0 | -0 | -0 | -0 | Upgrade
|
| Revenue | 123,769 | 119,877 | 137,878 | 165,206 | 140,318 | Upgrade
|
| Revenue Growth (YoY) | 3.25% | -13.06% | -16.54% | 17.74% | 7.91% | Upgrade
|
| Cost of Revenue | 73,810 | 70,644 | 95,309 | 111,150 | 107,228 | Upgrade
|
| Gross Profit | 49,959 | 49,232 | 42,570 | 54,056 | 33,090 | Upgrade
|
| Selling, General & Admin | 42,172 | 48,280 | 41,894 | 37,191 | 31,962 | Upgrade
|
| Research & Development | 1,785 | 3,558 | 2,639 | 2,414 | 3,090 | Upgrade
|
| Amortization of Goodwill & Intangibles | 66.17 | 81.93 | 96.74 | 296.67 | 414.05 | Upgrade
|
| Other Operating Expenses | 270.06 | 317.14 | 264.6 | 208.57 | 231.86 | Upgrade
|
| Operating Expenses | 43,709 | 54,246 | 47,148 | 42,826 | 36,027 | Upgrade
|
| Operating Income | 6,250 | -5,014 | -4,578 | 11,230 | -2,938 | Upgrade
|
| Interest Expense | -2,317 | -2,846 | -3,244 | -2,895 | -3,647 | Upgrade
|
| Interest & Investment Income | 307.85 | 520.97 | 725.08 | 251.11 | 118.76 | Upgrade
|
| Currency Exchange Gain (Loss) | -1,382 | 996.66 | 41.68 | -470.14 | -533.35 | Upgrade
|
| Other Non Operating Income (Expenses) | 66.55 | 1,771 | 689.17 | -2,374 | 1,952 | Upgrade
|
| EBT Excluding Unusual Items | 2,925 | -4,571 | -6,367 | 5,741 | -5,047 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -186.4 | -201.64 | -320.2 | -708.55 | Upgrade
|
| Gain (Loss) on Sale of Assets | 321.68 | 137.86 | 264.89 | -40.55 | 1.28 | Upgrade
|
| Asset Writedown | -268.5 | -689.52 | -9,411 | -5,181 | -1,337 | Upgrade
|
| Other Unusual Items | - | - | - | 0.01 | -595.12 | Upgrade
|
| Pretax Income | 2,978 | -5,309 | -15,715 | 199.42 | -7,687 | Upgrade
|
| Income Tax Expense | -289.6 | -102.59 | -126.83 | -4,504 | 291.74 | Upgrade
|
| Earnings From Continuing Operations | 3,268 | -5,206 | -15,588 | 4,704 | -7,978 | Upgrade
|
| Earnings From Discontinued Operations | -27.15 | -14.05 | - | - | - | Upgrade
|
| Net Income to Company | 3,241 | -5,220 | -15,588 | 4,704 | -7,978 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 660.21 | Upgrade
|
| Net Income | 3,241 | -5,220 | -15,588 | 4,704 | -7,318 | Upgrade
|
| Net Income to Common | 3,241 | -5,220 | -15,588 | 4,704 | -7,318 | Upgrade
|
| Shares Outstanding (Basic) | 24 | 24 | 24 | 24 | 22 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 24 | 24 | 24 | 22 | Upgrade
|
| Shares Change (YoY) | -0.50% | 0.16% | 0.38% | 7.17% | 11.67% | Upgrade
|
| EPS (Basic) | 136.00 | -218.00 | -651.97 | 197.49 | -329.29 | Upgrade
|
| EPS (Diluted) | 136.00 | -218.00 | -652.00 | 197.00 | -329.29 | Upgrade
|
| Free Cash Flow | 3,597 | 2,357 | 6,331 | 15,051 | 4,783 | Upgrade
|
| Free Cash Flow Per Share | 150.95 | 98.42 | 264.80 | 631.92 | 215.23 | Upgrade
|
| Gross Margin | 40.37% | 41.07% | 30.88% | 32.72% | 23.58% | Upgrade
|
| Operating Margin | 5.05% | -4.18% | -3.32% | 6.80% | -2.09% | Upgrade
|
| Profit Margin | 2.62% | -4.35% | -11.31% | 2.85% | -5.21% | Upgrade
|
| Free Cash Flow Margin | 2.91% | 1.97% | 4.59% | 9.11% | 3.41% | Upgrade
|
| EBITDA | 12,781 | 891.05 | 1,368 | 17,936 | 3,344 | Upgrade
|
| EBITDA Margin | 10.33% | 0.74% | 0.99% | 10.86% | 2.38% | Upgrade
|
| D&A For EBITDA | 6,532 | 5,905 | 5,947 | 6,706 | 6,282 | Upgrade
|
| EBIT | 6,250 | -5,014 | -4,578 | 11,230 | -2,938 | Upgrade
|
| EBIT Margin | 5.05% | -4.18% | -3.32% | 6.80% | -2.09% | Upgrade
|
| Advertising Expenses | 1,061 | 1,175 | 1,055 | 636.46 | 722.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.